Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bone Biologics (BBLG) Interest Expenses (2016 - 2021)

Bone Biologics has reported Interest Expenses over the past 2 years, most recently at $1.5 million for Q4 2017.

  • Quarterly Interest Expenses changed N/A to $1.5 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2017, up 328.55% year-over-year, with the annual reading at $805109.0 for FY2021, 19.33% down from the prior year.
  • Interest Expenses was $1.5 million for Q4 2017 at Bone Biologics, up from $1.2 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $1.5 million in Q4 2017 and troughed at $310089.0 in Q1 2016.